How does French tarragon work as a digestive aid?

French tarragon contains volatile oils including estragole, ocimene, and terpinolene, which act as carminatives to relieve digestive discomfort. These compounds help relax smooth muscle in the gastrointestinal tract through antispasmodic activity, reducing cramping and bloating. The herb also stimulates digestive secretions to improve overall digestion. Evidence level: C (preliminary clinical evidence and traditional use support this mechanism).

Does French tarragon interact with any medications?

French tarragon has no well-documented drug interactions in current literature. However, due to limited research, caution is advised when taking blood thinners, as the herb contains compounds that may theoretically affect clotting. The estragole content has raised theoretical concerns about liver enzyme interactions. Always consult a healthcare provider before combining herbs with prescription medications. Evidence level: D (insufficient evidence for interactions).

What is the recommended dosage for French tarragon?

The standard adult dosage for French tarragon is 2-4 grams of dried herb daily, typically prepared as a tea or used in culinary applications. This amount provides therapeutic benefits while staying within safe consumption limits. Higher doses should be avoided due to estragole content. For tea, steep 1-2 teaspoons of dried herb in hot water for 10-15 minutes. Evidence level: C (traditional use with some clinical guidance).

Is French tarragon safe during pregnancy?

French tarragon is considered unsafe during pregnancy and should be avoided in medicinal amounts. The herb contains estragole, which has demonstrated potential carcinogenic and genotoxic effects in animal studies. High doses may stimulate uterine contractions and affect menstrual cycles. Pregnant women, those trying to conceive, and breastfeeding mothers should not use medicinal doses. Culinary amounts in food are generally considered acceptable. Evidence level: C.

What is French tarragon used for medicinally?

French tarragon has been used in European folk medicine primarily as a digestive stimulant and carminative to relieve bloating, gas, and stomach cramps. It also has traditional use for menstrual regulation and as an antispasmodic for muscle cramps. The herb contains antioxidant compounds like rutin. While these uses are well-established in traditional medicine, clinical evidence remains limited. Evidence level: C (preliminary evidence supporting traditional uses).

Artemisia Dracunculus (Artemisia dracunculus)

PubMed-compiled information sheet

This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.

Compiled from 30 PubMed articles · model: gemma4:31b

Summary

Artemisia dracunculus (tarragon) is a perennial herb used as a spice and traditional remedy with documented anti-inflammatory, analgesic, and antimicrobial properties [PMID:33927629, PMID:21942448].

Background

Artemisia dracunculus L., belonging to the Asteraceae family, is a species utilized as a spice and medicinal herb across Asia, Europe, and the Americas [PMID:33927629, PMID:21942448]. Two primary cultivars, Russian and French, are widely used and differ in morphology, ploidy level, and chemical composition [PMID:21942448].

Traditional uses

In traditional Asian medicine (particularly in Iran, Pakistan, Azerbaijan, and India), it is used to treat digestive system diseases and as an analgesic, hypnotic, antiepileptic, anti-inflammatory, antipyretic agent, and remedy for helminthiasis [PMID:33927629].

Active compounds

Key bioactive secondary metabolites include essential oils (containing estragole, methyleugenol, eugenol, beta-cis-ocimene, beta-trans-ocimene, and l-limonene), flavonoids (such as kaempferol), phenolic acids, coumarins (including 5,7-Dihydroxy-4-Methylcoumarin and herniarine), and alkamides (such as pellitorine, neopellitorine A, and neopellitorine B) [PMID:33927629, PMID:21942448, PMID:11730872, PMID:38068651, PMID:33746262, PMID:39800268, PMID:36082856].

Mechanism of action

The herb exhibits antioxidant and anti-inflammatory effects by inhibiting reactive oxygen species (ROS), interleukin 8 (IL-8), and tumour necrosis factor α (TNF-α) [PMID:32903580]. Specific compounds like 5,7-Dihydroxy-4-Methylcoumarin may ameliorate osteoporosis via the AKT1 pathway [PMID:39800268]. Certain alkamides act as inhibitors of α-melanocyte-stimulating hormone (α-MSH) induced melanin production [PMID:21821921] and as cytochrome P450 (CYP3A4) inhibitors [PMID:22738981].

Clinical evidence

Evidence CInflammation and Pain

Pharmacological studies have confirmed anti-inflammatory and analgesic effects [PMID:33927629].

Evidence DHyperglycemia/Diabetes

In vivo rodent studies highlight potential antihyperglycemic effects [PMID:21942448]; specific extracts (PMI5011) improve blood glucose and insulin sensitivity via skeletal muscle [PMID:37686232].

Evidence DAutoimmune Encephalomyelitis (EAE)

Aqueous extract (500 mg/kg) significantly ameliorated clinical scores of EAE in mice [PMID:32245296].

Evidence DOsteoporosis

The compound 5,7-Dihydroxy-4-Methylcoumarin enhances osteoblastogenesis and ameliorates glucocorticoid-induced osteoporosis in zebrafish models [PMID:39800268].

Evidence CNeuropathic Pain

Identified as a plant that exhibits protective effects on neuropathic pain [PMID:29796216].

Safety & adverse effects

Concerns exist regarding the hepatocarcinogenicity of estragole and methyleugenol [PMID:21942448, PMID:11077188, PMID:27761422]. However, no acute toxicity or mutagenic activity has been reported at doses relevant for human consumption, and water extracts are considered low risk [PMID:21942448]. One case report noted a life-threatening glottal edema in a patient with pre-existing sunflower allergy who showed strong sensitization against mugwort and tarragon [PMID:16285482].

Drug interactions

Alkamides from A. dracunculus have been identified as effective dose-dependent inhibitors of cytochrome P450 3A4 (CYP3A4) activity [PMID:22738981].

Evidence summary

The evidence is primarily based on in vitro studies, animal models (rodents, zebrafish), and literature reviews. There is a lack of human clinical trials to establish standardized therapeutic dosages and efficacy.

PubMed sources

1.PMID: 33927629 (2021) — Artemisia dracunculus (Tarragon): A Review of Its Traditional Uses, Phytochemistry and Pharmacology. · Frontiers in pharmacology
2.PMID: 23010670 (2013) — Toxicological and mutagenic analysis of Artemisia dracunculus (tarragon) extract. · Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
3.PMID: 21942448 (2011) — Artemisia dracunculus L. (tarragon): a critical review of its traditional use, chemical composition, pharmacology, and safety. · Journal of agricultural and food chemistry
4.PMID: 11730872 (2001) — Alkamides from Artemisia dracunculus. · Phytochemistry
5.PMID: 40863944 (2025)

Artemisia Dracunculus

Sources & Citations